AL
BMY icon

ADE LLC’s Bristol-Myers Squibb BMY Stock Holding History

ADE LLC’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,430
Closed -$144K – 100
2021
Q3 		$144K Sell
2,430
-170
-7% -$11.2K 0.13% 82
2021
Q2 		$174K Buy
2,600
+200
+8% +$13K 0.16% 79
2021
Q1 		$152K Sell
2,400
-225
-9% -$14K 0.15% 82
2020
Q4 		$163K Buy
+2,625
New +$161K 0.13% 94

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

ADE LLC's BMY Position: Q4 2021 in Review

ADE LLC sold out of Bristol-Myers Squibb (BMY) in Q4 2021, closing a stake of 2,430 shares — an estimated $144K sold.

ADE LLC first reported a position in BMY in Q4 2020 and held it in 4 quarters. The position peaked at $174K in Q2 2021. 2,444 funds tracked by Wall St. Rank hold BMY as of Q4 2021.

  • ADE LLC reported no remaining Bristol-Myers Squibb position as of Q4 2021 after selling out during the quarter.
  • ADE LLC sold 2,430 Bristol-Myers Squibb shares in Q4 2021, an estimated $144K.
  • ADE LLC first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 4 quarters.
  • ADE LLC's Bristol-Myers Squibb position peaked at $174K in Q2 2021.
  • 2,444 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.

Based on ADE LLC's 13F filing for Q4 2021, filed 14 Feb 2022.